Antimetastatic effect of hepatotropic liposomal adriamycin on human metastatic liver tumors

Surgery Today

Volumn 31, Issue 5, 2001, Pages 414-420

  Matsuda, Iwao ^a,b   Konno, Hiroyuki ^a   Tanaka, Tatsuo ^a   Nakamura, Satoshi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Department of Surgery   (Japan)

Author keywords

Chemotherapy; Galactose receptor; Hepatotropic liposome; Human colon cancer; Liver metastasis

Indexed keywords

DOXORUBICIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BASEMENT MEMBRANE; CANCER CHEMOTHERAPY; CANCER TRANSPLANTATION; DRUG EFFECT; ENDOTHELIUM CELL; GENE TARGETING; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIVER METASTASIS; LIVER TUMOR; MOUSE; NONHUMAN; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; COLONIC NEOPLASMS; DOXORUBICIN; HUMANS; INJECTIONS, INTRAVENOUS; LIPOSOMES; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; RATS; RECEPTORS, CELL SURFACE; TRANSPLANTATION, HETEROLOGOUS; WEIGHT LOSS;

EID: 0035030394     PISSN: 09411291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005950170132     Document Type: Article

References (37)

1. Maruo Y, Konno H, Baba S (1992) Therapeutic effect of liposomal adriamycin in combination with tumor necrosis factor-α. J Surg Oncol 49:20-24
2. Kato T, Nemoto R (1971) Microencapsulation of mitomycin C for intra-arterial infusion chemotherapy. Proc Jpn Acad 54(B):413-417
3. Gregoriadis G (1980) The liposome drug-carrier concept: its development and future. In: G. Gregoriadis G, Allison AC (eds) Liposomes in biological systems. Wiley, New York, pp 25-86
4. Weinstein JN (1984) Liposomes as drug carriers in cancer therapy. Cancer Treat Rep 68:127-135
5. Horowitz AT, Barenholz Y, Gabizon AA (1992) In vivo cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug release. Biochim Biophys Acta 1109: 203-209
6. Gabizon A, Goren D, Fuks Z, Barenhorz Y, Dagan A, Meshorer A (1983) Enhancement of adriamycin delivery to liver metastatic cells with increased tumouricidal effect using liposomes as drug carriers. Cancer Res 43:4730-4735
7. Storm G, Roerdink FH, Steerenberg PA, de Jong WH, Crommelin DJA (1987) Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model. Cancer Res 47:3366-3372
8. Vaage J, Donovan D, Mayhew E, Uster P, Woodle M (1993) Therapy of mouse mammary carcinomas with vincristine and doxorubicin encapsulated in sterically stabilized liposomes. Int J Cancer 54:959-964
9. Gabizon A, Goren D, Fuks Z, Meshorer A, Barenhorz Y (1985) Superior therapeutic activity of liposome-associated adriamycin in a murine metastatic tumor model. Br J Cancer 51:681-689
10. Gabizon A, Dagan A, Goren D, Branholz Y, Fuks Z (1982) Liposomes as in vivo carriers of adriamycin: reduced cardiac uptake and preserved antitumor activity in mice. Cancer Res 42:4734-4739
11. Wisse E, De Zeanger R, Jacobs R (1982) Lobular gradients in endothelial fenestrate and sinusoidal diameter favour centroglobular exchange processes: a scanning EM study. In: Knook DL, Wisse E (eds) Sinusoidal liver cells. Elsevier, Amsterdam, pp 61-67
12. Segal AW, Wills EJ, Richmond JE, Slavin G, Black CDV, Gregoriadis G (1974) Morphological observations on the cellular and subcellular destination of intravenously administered liposomes. Br J Exp Pathol 55:320
13. Poste G, Bucana C, Raz A, Bugelski P, Kirsh R, Fidler IJ (1982) Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery. Cancer Res 42:1412-1422
14. Kao YJ, Juliano RL (1981) Interactions of liposomes with the reticulo-endothelial system. Effects of reticulo-endothelial blockade on the clearance of large unilamellar vesicles. Biochim Biophys Acta 677:453-457
15. Roerdink F, Dijkstra J, Hartman G, Bolscher B, Scherphof G (1981) The involvement of parenchymal, Kupffer and endothelial liver cells in the hepatic uptake of intravenous injection liposomes. Biochim Biophys Acta 677:79-83
16. Ridge JA, Collin C, Bading JR, Hancock C, Conti PS, Daly JM, Raaf JH (1988) Increased adriamycin levels in hepatic implants of Rabbit Vx-2 carcinoma from resional infusion. Cancer Res 48: 4584-4587
17. Zou Y, Horikoshi I, Ueno M, Gu X, Soler RP (1992) Targeting liver tumors by administering liposomal doxorubicin into the hepatic artery. Int J Cancer 51:232-237
18. Mayer LD, Tai LCL, Ko DSC, Masin D, Ginsberg RS, Cullis PR, Bally MB (1989) Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res 49:5922-5930
19. Ashwell G, Harford J (1982) Carbohydrate-specific receptors of the liver. Annu Rev Biochem 51:531-554
20. Ashwell G, Morell AG (1974) The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol 41:99-128
21. Hara T, Ishihara H, Aramaki Y, Tsuchiya S (1988) Specific uptake of asialofetuin-labeled liposomes by isolated hepatocytes. Int J Pharm 42:69-75
22. Spanjer HH, Scherphof GL (1983) Targeting of lactosylceramide-containing liposomes to hepatocytes in vivo. Biochim Biophys Acta 734:40-47
23. Sasaki A, Murahashi N, Yamada H, Morikawa A (1994) Synthesis of novel galactosyl ligands for liposomes and their accumulation in the rat liver. Biol Pharm Bull 17:680
24. Bangham AD, Horne RW (1964) Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope. J Mol Biol 8:660
25. Sharma D, Chelvi TP, Kaur J, Ralhan R (1998) Thermosensitive liposomal taxol formulation: heat-mediated targeted drug delivery in murine melanoma. Melanoma Res 8:240-244
26. Khanna C, Anderson PM, Hasz DE, Katsanis E, Neville M, Klausner JS (1997) Interleukin-2 liposome inhalation therapy is safe and effective for dogs with spontaneous pulmonary metastases. Cancer 79:1409-1421
27. Vaage J, Mayhew E, Lasic D, Martin F (1992) Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long circulating liposomes. Int J Cancer 51:942-948
28. Konno H, Maruo Y, Matsuda I, Nakamura S, Baba S (1995) Intra-arterial liposomal adriamycin for metastatic adenocarcinoma of the liver. Eur Surg Res 27:301-306
29. Pisani P, Parkin DM, Bray F, Ferlay J (1999) Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83: 18-29
30. Martinet O, Reis ED, Gillet M (1999) Gene therapy and liver metastasis. Schweiz Med Wochenschr 129:1187-1195
31. Okamoto K, Oshika Y, Fukushima Y, Yoshimura M, Ohnishi Y, Tokunaga T, Hashimoto T, Hatanaka H, Tomii Y, Yoshida Y, Miura S, Tsuchida T, Kijima H, Yamazaki H, Nakamura M, Ueyama Y (1999) Inhibition of liver metastasis of colon cancer by in vivo administration of anti-vascular endothelial growth factor antibody. Oncol Rep 6:553-556
32. Hasegawa S, Koshikawa N, Momiyama N, Moriyama K, Ichikawa Y, Ishikawa T, Mitsuhashi M, Shimada H, Miyazaki K (1998) Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model. Int J Cancer 76:812-816
33. Ghosh P, Bachhawat BK, Surolia A (1981) Synthetic glycolipids: interaction with galactose-binding lectin and hepatic cells. Arch Biochem Biophys 206:454-457
34. Armad I, Longenecker M, Samuel J, Allen TM (1993) Antibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in mice. Cancer Res 53:1484-1488
35. Murahashi N, Yamada H, Watanabe H, Higashi K, Miyoshi S, Yamauchi H, Nakabayashi S (1996) Synthesis and evaluation of neoglycolipid for liposome modification. Drug Deliv Syst 11:91-97
36. Cay O, Kruskal JB, Nasser I, Thomas P, Clouse ME (1997) Liver metastases from colorectal cancer: drug delivery with liposome-encapsulated doxorubicin. Radiology 205:95-101
37. Harasym TO, Cullis PR, Bally MB (1997) Intratumor distribution of doxorubicin following i.v. administration of drug encapsulated in egg phosphatidylcholine/cholesterol liposomes. Cancer Chemother Pharmacol 40:309-317